(2023). A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer. Thromb Haemost. http://doi.org/10.1055/a-2145-7238
. A. Cohen
First name
A.
Middle name
T.
Last name
Cohen
(2014). Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer. Thromb Haemost. http://doi.org/10.1160/th13-09-0793
. (2015). Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013. Heart. http://doi.org/10.1136/heartjnl-2015-307808
. (2016). Testosterone treatment and risk of venous thromboembolism: population based case-control study. Bmj. http://doi.org/10.1136/bmj.i5968
. (2016). Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study. J Thromb Haemost. http://doi.org/10.1111/jth.13337
. (2017). Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study. Thromb Haemost. http://doi.org/10.1160/th15-08-0686
. (2019). Predicting atrial fibrillation in primary care using machine learning. PLoS One. http://doi.org/10.1371/journal.pone.0224582
. (2019). Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study. Thromb Haemost. http://doi.org/10.1055/s-0039-1683429
. (2020). Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer. Thromb Haemost. http://doi.org/10.1055/s-0040-1709527
. (2020). Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients. Br J Haematol. http://doi.org/10.1111/bjh.16383
.